autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2002 (NCT01082198)
Timeline
Indications
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccine
- klh-pulsed autologous dendritic cell vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00868114 | Phase 2 | Jul 1, 2006 | East Carolina University, Leo W. Jenkins Cancer Center, University of South Florida |
| NCT01082198 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2002 | Maria Sklodowska Curie Children's Hospital |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| East Carolina University | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Leo W. Jenkins Cancer Center | Academic/Hospital | 1 | 1 | 1 | 2006 |
| Maria Sklodowska Curie Children's Hospital | Academic/Hospital | 1 | 1 | 1 | 2002 |
| University of South Florida | Academic/Hospital | 1 | 0 | 1 | 2006 |
4 organizations
Page 1 / 1